Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Gomeni

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Psychiatry Research|August 6, 2023
A new method for analyzing clinical trials in depression based on individual propensity to respond to placebo estimated using artificial intelligenceRoberto Gomeni, Françoise Bressolle-Gomeni, Maurizio Fava
Journal of Clinical Pharmacology|February 23, 2016
Response Surface Analysis and Nonlinear Optimization Algorithm for Maximization of Clinical Drug Performance: Application to Extended-Release and Long-Acting Injectable PaliperidoneRoberto Gomeni, Françoise Bressolle-Gomeni, Maurizio Fava
Innovations in Clinical Neuroscience|October 7, 2022
Quantitative Characterization of the Smoothness of Extended-release Methylphenidate Pharmacokinetic ProfilesMichelle D Po, Roberto Gomeni, Bev Incledon
Translational Psychiatry|April 29, 2023
Artificial intelligence approach for the analysis of placebo-controlled clinical trials in major depressive disorders accounting for individual propensity to respond to placeboRoberto Gomeni, Françoise Bressolle-Gomeni, Maurizio Fava
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 22, 2015
A Novel Methodology to Estimate the Treatment Effect in Presence of Highly Variable Placebo ResponseRoberto Gomeni, Navin Goyal, Françoise Bressolle, et al.
IEEE Transactions on Bio-Medical Engineering|August 18, 2011
Bayesian population modeling of phase I dose escalation studies: Gaussian process versus parametric approachesAlberto Russu, Italo Poggesi, Roberto Gomeni, et al.
Journal of Clinical Psychopharmacology|June 27, 2020
Model-Based Approach for Establishing the Predicted Clinical Response of a Delayed-Release and Extended-Release Methylphenidate for the Treatment of Attention-Deficit/Hyperactivity DisorderRoberto Gomeni, Marina Komolova, Bev Incledon, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 22, 2020
Model based approach for estimating the dosage regimen of indomethacin a potential antiviral treatment of patients infected with SARS CoV-2Roberto Gomeni, Tianhong Xu, Xuejuan Gao, et al.
Journal of Psychiatric Research|January 22, 2008
Sensitivity of the individual items of the Hamilton depression rating scale to response and its consequences for the assessment of efficacyGijs Santen, Roberto Gomeni, Meindert Danhof, et al.
Translational Psychiatry|December 14, 2023
Interpreting clinical trial outcomes complicated by placebo response with an assessment of false-negative and true-negative clinical trials in depression using propensity-weightingRoberto Gomeni, Seth Hopkins, Françoise Bressolle-Gomeni, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Psychiatry Research|August 6, 2023
A new method for analyzing clinical trials in depression based on individual propensity to respond to placebo estimated using artificial intelligenceRoberto Gomeni, Françoise Bressolle-Gomeni, Maurizio Fava
Journal of Clinical Pharmacology|February 23, 2016
Response Surface Analysis and Nonlinear Optimization Algorithm for Maximization of Clinical Drug Performance: Application to Extended-Release and Long-Acting Injectable PaliperidoneRoberto Gomeni, Françoise Bressolle-Gomeni, Maurizio Fava
Innovations in Clinical Neuroscience|October 7, 2022
Quantitative Characterization of the Smoothness of Extended-release Methylphenidate Pharmacokinetic ProfilesMichelle D Po, Roberto Gomeni, Bev Incledon
Translational Psychiatry|April 29, 2023
Artificial intelligence approach for the analysis of placebo-controlled clinical trials in major depressive disorders accounting for individual propensity to respond to placeboRoberto Gomeni, Françoise Bressolle-Gomeni, Maurizio Fava
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 22, 2015
A Novel Methodology to Estimate the Treatment Effect in Presence of Highly Variable Placebo ResponseRoberto Gomeni, Navin Goyal, Françoise Bressolle, et al.
IEEE Transactions on Bio-Medical Engineering|August 18, 2011
Bayesian population modeling of phase I dose escalation studies: Gaussian process versus parametric approachesAlberto Russu, Italo Poggesi, Roberto Gomeni, et al.
Journal of Clinical Psychopharmacology|June 27, 2020
Model-Based Approach for Establishing the Predicted Clinical Response of a Delayed-Release and Extended-Release Methylphenidate for the Treatment of Attention-Deficit/Hyperactivity DisorderRoberto Gomeni, Marina Komolova, Bev Incledon, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 22, 2020
Model based approach for estimating the dosage regimen of indomethacin a potential antiviral treatment of patients infected with SARS CoV-2Roberto Gomeni, Tianhong Xu, Xuejuan Gao, et al.
Journal of Psychiatric Research|January 22, 2008
Sensitivity of the individual items of the Hamilton depression rating scale to response and its consequences for the assessment of efficacyGijs Santen, Roberto Gomeni, Meindert Danhof, et al.
Translational Psychiatry|December 14, 2023
Interpreting clinical trial outcomes complicated by placebo response with an assessment of false-negative and true-negative clinical trials in depression using propensity-weightingRoberto Gomeni, Seth Hopkins, Françoise Bressolle-Gomeni, et al.
Pageof 8